Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,884 INR | -0.55% | +2.90% | -6.13% |
16/04 | Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak | CI |
28/03 | Alkem Laboratories Forms Subsidiary for Medical Devices Business | MT |
Sales 2024 * | 129B 1.55B | Sales 2025 * | 142B 1.7B | Capitalization | 587B 7.04B |
---|---|---|---|---|---|
Net income 2024 * | 18.67B 224M | Net income 2025 * | 21.7B 260M | EV / Sales 2024 * | 4.39 x |
Net cash position 2024 * | 20.12B 241M | Net cash position 2025 * | 27.86B 334M | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
27.2
x | Employees | 16,871 |
Yield 2024 * |
0.88% | Yield 2025 * |
0.99% | Free-Float | 36.2% |
Latest transcript on Alkem Laboratories Limited
1 day | -0.55% | ||
1 week | +2.90% | ||
Current month | -1.18% | ||
1 month | -2.51% | ||
3 months | -1.85% | ||
6 months | +32.28% | ||
Current year | -6.13% |
Managers | Title | Age | Since |
---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 22/23/22 |
Nitin Agrawal
DFI | Director of Finance/CFO | - | 01/02 |
Manish Narang
CMP | Compliance Officer | 54 | 01/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Director/Board Member | 77 | 16/15/16 | |
Chief Executive Officer | 84 | 08/73/08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 6 M€ | +6.07% | - | |
0.01% | 31 M€ | +3.50% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 4,884 | -0.55% | 140 520 |
26/24/26 | 4,910 | +0.88% | 160,192 |
25/24/25 | 4,868 | +3.11% | 150,059 |
24/24/24 | 4,721 | +0.35% | 55,269 |
23/24/23 | 4,704 | -0.87% | 145,622 |
Delayed Quote NSE India S.E., April 29, 2024 at 05:10 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.13% | 7.04B | |
+26.51% | 661B | |
+27.27% | 566B | |
-6.35% | 352B | |
+20.40% | 332B | |
+3.37% | 283B | |
+14.36% | 231B | |
+5.22% | 200B | |
-9.00% | 195B | |
-4.77% | 145B |
- Stock Market
- Equities
- ALKEM Stock